An observational single-center study of nivolumab in Indian patients with recurrent advanced non-small cell lung cancer

Conclusion: Data from our study suggest nivolumab is well-tolerated and effective in Indian patients with recurrent advanced NSCLC after failure of the multiple first lines of platinum-based combination chemotherapy.

Source: Indian Journal of Cancer - October 10, 2019 Category: Cancer & Oncology Authors: Naresh Somani Pawan Agarwal Harish Singhal Abhishek K Singh Abhilasha Sinha Rajshri Somani Jia Agarwal Shaurya Dugar Source Type: research